Cell plasticity, defined as the ability to undergo phenotypical transformation in a reversible 12 manner, is a physiological processes that also exert important roles in disease progression Two forms 13 of cellular plasticity are epithelial-mesenchymal transition (EMT) and its inverse process, 14 mesenchymal-epithelial transition (MET). These processes have been correlated to the poor outcome 15 of different types of neoplasias as well as drug resistance development. Since EMT/MET are 16 transitional processes, we have generated and validated a reporter cell line. Specifically, a far-red 17 fluorescent protein was knocked-in in-frame with the mesenchymal gene marker VIMENTIN (VIM) 18 in H2170 lung cancer cells. The vimentin reporter cells (VRCs) are a reliable model for studying EMT 19 and MET showing cellular plasticity upon a series of stimulations. These cells are a robust platform 20 to dissect the molecular mechanisms of these processes, and for drug discovery in vitro and in the 21 future in vivo.
Introduction

26
The ability of cells to temporally acquire different characteristics, also known as cell plasticity, plays 27 essential roles in physiological and pathophysiological processes [1] . Epithelial cells might transform 28 to a mesenchymal phenotype and return to epithelial phenotype by epithelial-mesenchymal 3 of 19 another 2 days in 5 µg/ml of puromycin. The positive single cell clones obtained by dilution were 81 genotyped what was described in details in Genotyping section.
82
Plasmid vectors used in functional assays
83
For functional experiments in H2170 knocked-in cells we used (FLAG) Snail 6SA (active Snail) 84 plasmid which was a gift from Mien-Chie Hung (Addgene plasmid # 16221) [16] , TGFB1-bio-His 85 (proTGFβ) which was a gift from Gavin Wright (Addgene plasmid # 52185) [17] and HA-OVOL2 86 (OVOL2) expressing plasmid was a kindly gift from Changwon Park [18] . EMT/MET in VRCs was 87 studied with the use of expressing vectors harbouring genomic fragments of microRNA-200 family 88 (miR-145, miR-200b, miR-200c, miR-205) 
103
The vectors harbouring miR-145, miR-200b, miR-200c and miR-205 genomic fragments were created 104 by inserting each PCR amplified microRNAs gene into the 3'UTR of mNeon fluorescent protein 105 expressing vector (pmR-mNeon). All listed above genomic fragments were amplified using tiHybrid 106 DNA polymerase (EURx) from the DNA, which was purified from the blood of healthy volunteer 107 with the use of GeneAll Exgene Blood SV kit (GeneAll). The sets of primers used for amplification of 108 miR-145, miR-200b, miR-200c and miR-205 fragments were miR145-F/miR145-R, miR-200b-F/miR-Upon 2 min of initial incubation at 50 ˚C followed by 2 min incubation at 95˚C, cDNA was amplified 141 in 45 cycles consisting of 15 s denaturation at 95˚C, 30 s annealing at 60˚C and 20 s elongation at 72˚C.
142
Obtained fluorescence data was analyzed using a relative quantification (RQ) method 2^(-ΔΔCT) for 143 estimating expression fold changes normalized to dim-VRCs and 2^(-ΔCT) method for comparison 144 of the expression of each measured gene. The assessed genes expression (VIM, mCardinal, CDH1, 145 ZEB1 and ZEB2) were normalized to GAPDH level, which was measured with the use of GAPDH-F 146 and GAPDH-R oligonucleotides. GAPDH was previously confirmed as stably expressed at mRNA 147 level in H2170 as well as in VRCs (mean Cp = 17.14; median Cp = 17.09; SD = 0.5209; SEM = 0.03638; 148 N = 205). Expression of VIM was measured using VIM-F and VIM-R primers, measurement of 149 mCardinal level was conducted using mCard-F and mCard-R primers, whereas estimation of CDH1 150 expression was performed at mRNA level with the use of Cdh1-F and Cdh1 -R oligonucleotides.
151
ZEB1 and ZEB2 quantifications were performed using ZEB1F/R and ZEB2F/R pairs of 152 oligonucleotides, respectively. TWIST1 and TWIST2 quantifications were performed using 153 TWIST1F/R and TWIST2F/R pairs of oligonucleotides, respectively. The primers were designed as 154 intron-spanning to avoid any influence of genomic DNA contamination and was listed in 155 Supplementary materials (Table S1 ). Figure S1 ). After sorting, the purity of sorted cells was confirmed by flow cytometry and reaches 166 more than 97%. The resulting two populations of VRCs were named dim-VRCs and bright-VRCs. The targeting sequence in H2170 cells was confirmed by sequencing ( Figure S1 ). The H2170 lung 212 cancer cells were nucleofected with the CRISPR and template (vKIT, Figure 1A 
217
The template cassette, containing HA-T2A-FLAG-mCardinal-HA, was flanked by two gRNA targeting 218 sequences identical to those for VIM gene in order to linearize the knock-in insert and promote 219 efficient Homology directed repair (HDR).
220
Two days after nucleofection, the cells were selected using puromycin (1 µg/ml) for another two days.
221
Single cell clones were obtained by dilution, further they were genotyped by PCR with the efficiency 222 near 2,7% (3/112). Single cell clones, confirmed by PCR, were called VRCs and used in downstream 
235
To determine if fusing mCardinal to VIM would result in a better cellular distribution, the T2A 236 peptide sequence was modified by substitution of the P16A and P18A in the T2A sequence. The 237 resulting vector (VIM-mCardinal) was overexpressed in HEK293 cells, showing granular localisation 7 of 19 too (Fig S3 D-F) . Overexpression of VIM-mCardinal in HEK293 cells showed that this fusion protein 239 localised only in large granules in the cell and is similar in comparison to the fluorescence in VIM-
240
T2A-mCardinal overexpressing cells, where the fluorescence was shown in similar granules as well 241 as diffusing in the cytoplasm ( Figure S3 ).
242
Since the foci in the Vim-T2A-mCardinal cells corresponded to fused Vim-mCardinal fusions, likely 243 resulting from inefficient T2A processing, were brighter than if evenly distributed throughout the 244 cytoplasm, we considered them as a baseline.
245
To further characterise VRCs, they were then sorted according to the fluorescence intensity, resulting 246 in two populations (dim-VRCs and bright-VRCs) that differ about 3 times in mCardinal fluorescence 247 intensity ( Figure S4) . That difference was reduced upon culturing to less than 2 fold mCardinal 248 intensity between dim-VRCs and bright-VRCs after 48 h ( Figure 2G ). VIM as well as mCardinal 249 expression measured at the transcriptional level confirmed that those two genes are expressed at 250 equal levels ( Figure 2H and S5 ).
251
The dim-VRCs where then exposed to a series of EMT-inducing factors, to analyse the correlation 252 between mesenchymal conversion and mCardinal expression. 
EMT markers vs reporter gene 254
The dim-VRCs were transfected with active Snai1 or proTGFβ expressing plasmids, which resulted 255 in a 2-fold increase in fluorescence, examined using confocal microscopy in 24 h or in 48 h after 256 transfection ( Figure 3A) . Correspondingly, the transcriptional levels of VIM as well as mCardinal 257 showed similar fold increase (RQ) ( Figure 3B 
OVOL2 and miRNAs overexpression modulates CDH1 expression in VRCs via ZEB1/2 repressors 271
In order to test if mesenchymal-like VRCs could reverse their phenotype into more epithelial, we (miR-145, miR-200b, miR-200c 339 and miR-205). The results were normalized to VRCs control (mock transfected) and shown as mean 
349
Mounting evidence shows that tumors are far more heterogenous than expected in due to genetic 350 diversity of the tumor cells as well as their phenotypic plasticity [22, 23] 
357
Among tumor cells there are some that undergo EMT, MET, or hybE/M, and in order to understand 358 the effects of cellular plasticity in biological and pathological processes, there is a need of reporters 359 that can determine the stage of a cell. Observing changes in mesenchymal and epithelial phenotype 360 as they occur, is a significant improvement in studying of molecular mechanism in cancer cells. H2170 361 cells was chosen because they have been a good model for to EMT and MET [30, 31] .
362
To-date EMT/MET is routinely studied by the use of exogenous reporter genes that are 363 heterologously expressed exhibiting interference of cis-and trans-regulatory elements, alternative 364 promoters or epigenetic events that resulted in obtaining unreliable data [32, 33] . These limitations 
376
Using a far-red fluorescent protein (mCardinal) which is simultaneously expressed with endogenous 377 VIM, but separate during translation due to the viral self-cleaving peptide (T2A). T2A was chosen 378 because, together with P2A, it have been reported as the most efficient from all tested self-cleaving 379 2A peptides [38] [39] [40] [41] , moreover T2A resulted in the least amount of "uncleaved" protein product 380 among the family of 2A peptides [39] [40] [41] . The stability and half-life of the 2 resulting proteins can 381 result in small changes in total expression, the two proteins are synthesized at a 1:1 ratio [41] . VIM 382 13 of 19 expression at the transcriptional level corresponded to that of mCardinal, and when stimulated, the 383 changes of VIM expression when hand-to-hand to those of mCardinal, evidencing that our strategy is 384 fully functional.
385
mCardinal was chosen by us mainly because this far-red monomeric protein is better for in vivo
